A TOX-ic axis of epigenetic stem cell maintenance and chemoresistance in colon cancer

Open Access

Primers provide a concise introduction into an important aspect of biology highlighted by a current PLOS Biology research article.

Christopher G. Hubert,

Affiliations Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio, United States of America, Case Comprehensive Cancer Center, Cleveland, Ohio, United States of America
⨯
Shaun R. Stauffer,

Affiliations Case Comprehensive Cancer Center, Cleveland, Ohio, United States of America, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
⨯
Justin D. Lathia

* E-mail: lathiaj@ccf.org

Affiliations Case Comprehensive Cancer Center, Cleveland, Ohio, United States of America, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, United States of America

https://orcid.org/0000-0003-3168-7290

⨯

Reader Comments (0)

Cancer stem cells
Is the Subject Area "Cancer stem cells" applicable to this article?

Thanks for your feedback.
Epigenetics
Is the Subject Area "Epigenetics" applicable to this article?

Thanks for your feedback.
Stem cell therapy
Is the Subject Area "Stem cell therapy" applicable to this article?

Thanks for your feedback.
Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Signaling networks
Is the Subject Area "Signaling networks" applicable to this article?

Thanks for your feedback.
Epigenetic therapy
Is the Subject Area "Epigenetic therapy" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Drug interactions
Is the Subject Area "Drug interactions" applicable to this article?

Thanks for your feedback.